Cargando…
Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood–Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation
[Image: see text] Despite limited evidence for infection of SARS-CoV-2 in the central nervous system, cognitive impairment is a common complication reported in “recovered” COVID-19 patients. Identification of the origins of these neurological impairments is essential to inform therapeutic designs ag...
Autores principales: | Chiang, Wesley, Stout, Angela, Yanchik-Slade, Francine, Li, Herman, Terrando, Niccolò, Nilsson, Bradley L., Gelbard, Harris A., Krauss, Todd D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463222/ https://www.ncbi.nlm.nih.gov/pubmed/37649833 http://dx.doi.org/10.1021/acsanm.3c02719 |
Ejemplares similares
-
Hybrid Amyloid Quantum Dot Nanoassemblies to Probe Neuroinflammatory Damage
por: Chiang, Wesley, et al.
Publicado: (2023) -
NeuroCOVID: it's time to join forces globally
por: Helbok, Raimund, et al.
Publicado: (2020) -
NeuroCOVID-19: a critical review
por: Guedes, Bruno Fukelmann
Publicado: (2022) -
URMC‐099 prophylaxis prevents hippocampal vascular vulnerability and synaptic damage in an orthopedic model of delirium superimposed on dementia
por: Miller‐Rhodes, Patrick, et al.
Publicado: (2022) -
Neutrophilia with damage to the blood-brain barrier and neurovascular unit following acute lung injury
por: Li, Herman, et al.
Publicado: (2023)